MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+27.19%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$497M
AUM Growth
+$497M
(+29%)
Cap. Flow
+$70.4M
Cap. Flow
% of AUM
14.17%
Top 10 Holdings %
Top 10 Hldgs %
64.94%
Holding
41
New
10
Increased
17
Reduced
1
Closed
7
Top Buys
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$31M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
$15.1M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$11.6M |
| 4 |
Xeris Biopharma Holdings
XERS
|
$10.4M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$6.85M |
Top Sells
| 1 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$28.3M |
| 2 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$22.5M |
| 3 |
uniQure
QURE
|
$7.01M |
| 4 |
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
|
$5.06M |
| 5 |
Arcutis Biotherapeutics
ARQT
|
$2.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cullinan Oncology
CGEM
$445M
| $82.3M | 16.57% | 7,648,268 | – | – |
|
|
ISEE
2
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $47.8M | 9.62% | 1,214,662 +168,971 | +16% | +$6.65M |
|
|
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $38.6M | 7.76% | 1,003,406 +805,600 | +407% | +$31M |
|
4
Geron
GERN
$893M
| $29.5M | 5.94% | 9,191,290 +789,725 | +9% | +$2.54M |
|
|
RETA
5
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $23.9M | 4.81% | 234,478 +57,604 | +33% | +$5.87M |
|
6
iTeos Therapeutics
ITOS
| $23.1M | 4.65% | 1,745,943 | – | – |
|
7
Intellia Therapeutics
NTLA
$1.22B
| $22.2M | 4.47% | 544,639 -27,820 | -5% | -$1.13M |
|
8
Iovance Biotherapeutics
IOVA
$807M
| $20.8M | 4.18% | 2,950,118 +335,141 | +13% | +$2.36M |
|
9
Repare Therapeutics
RPTX
$71.7M
| $17.3M | 3.49% | 1,639,849 | – | – |
|
10
Relay Therapeutics
RLAY
$619M
| $17M | 3.43% | 1,354,368 +128,734 | +11% | +$1.62M |
|
|
VERV
11
DELISTED
Verve Therapeutics
VERV
| $16.1M | 3.24% | 857,940 +54,439 | +7% | +$1.02M |
|
|
12
MoonLake Immunotherapeutics
MLTX
$3.54B
| $15.1M | 3.03% | +295,111 | New | +$15.1M |
|
13
Regenxbio
RGNX
$451M
| $13.1M | 2.64% | 656,718 +39,047 | +6% | +$781K |
|
|
KRTX
14
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $11.6M | 2.33% | +53,399 | New | +$11.6M |
|
15
Insmed
INSM
$28.8B
| $11.2M | 2.25% | 529,743 +130,551 | +33% | +$2.75M |
|
|
16
Xeris Biopharma Holdings
XERS
$1.26B
| $10.4M | 2.1% | +3,974,999 | New | +$10.4M |
|
17
Madrigal Pharmaceuticals
MDGL
$9.76B
| $8.78M | 1.77% | 38,011 +1,973 | +5% | +$456K |
|
18
Crinetics Pharmaceuticals
CRNX
$2.92B
| $8.63M | 1.74% | 479,053 +118,661 | +33% | +$2.14M |
|
19
Travere Therapeutics
TVTX
$1.56B
| $8.49M | 1.71% | 552,846 +239,204 | +76% | +$3.67M |
|
20
Revolution Medicines
RVMD
$7.1B
| $7.31M | 1.47% | 273,408 +26,386 | +11% | +$706K |
|
21
Werewolf Therapeutics
HOWL
$59.9M
| $7.28M | 1.47% | 2,388,011 | – | – |
|
|
22
KalVista Pharmaceuticals
KALV
$678M
| $6.85M | 1.38% | +761,538 | New | +$6.85M |
|
23
Axsome Therapeutics
AXSM
$6.05B
| $6.73M | 1.35% | 93,586 +23,184 | +33% | +$1.67M |
|
24
Amicus Therapeutics
FOLD
$2.34B
| $6.48M | 1.31% | 516,139 +127,847 | +33% | +$1.61M |
|
|
AVDL
25
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.34M | 1.28% | +384,990 | New | +$6.34M |
|